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Aging is thought to be associated with a higher susceptibility
to renal ischemia–reperfusion injury (IRI). To study whether
defective induction of hemeoxygenase-1 (HO-1, a protective
and anti-inflammatory enzyme) might contribute to this, we
found that while 12-month-old mice had similar baseline
renal function and HO-1 expression, the induction of HO-1
usually seen in ischemia–reperfusion was reduced. This was
also associated with worsened renal function and acute
tubular necrosis in the aged compared with young mice.
In the older mice, heme arginate (HA) induced HO-1 in the
cortex and medulla, significantly improved renal function,
and reduced tissue injury. Cellular HO-1 induction in the
medulla in response to injury or HA treatment was found
to be interstitial rather than epithelial, as evidenced by its
colocalization with macrophage markers. In vitro, HA
treatment of primary macrophages resulted in marked
HO-1 induction without impairment of classical activation
pathways. Macrophage depletion, caused by diphtheria toxin
treatment of 12-month-old CD11b-DTR transgenic animals,
resulted in the loss of interstitial HO-1-positive cells and
reversal of the protective phenotype of HA treatment. Thus,
failure of HO-1 induction following renal IRI worsens
structural and functional injury in older mice and represents
a therapeutic target in the elderly. Hence, HO-1-positive renal
macrophages mediate HA-induced protection in IRI.
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Acute kidney injury (AKI) is a devastating clinical condition
with a high morbidity and mortality.1 The elderly exhibit
both markedly increased susceptibility to AKI,2 and higher
rates of death and progression to end-stage renal disease.3,4
This heightened vulnerability to renal injury in the older
population is conventionally thought to be multifactorial in
etiology, with increased use of potentially nephrotoxic drugs
superimposed on conditions such as arteriosclerosis resulting
in an impaired ability to maintain adequate renal perfusion
in response to other systemic insults.
It is recognized that in addition to the acquisition of comorbid
conditions, aging also impacts on a cellular level as it may alter
the ability of a tissue to respond to stress or to regenerate in
response to injury.5 A key enzyme induced by cell stress is hemeo-
xygenase-1 (HO-1), which catalyzes the breakdown of highly
reactive free heme moieties. In addition to removing a source of
oxidative stress, heme metabolism generates carbon monoxide
and biliverdin that is subsequently converted to bilirubin by the
enzyme biliverdin reductase. These products of heme metabolism
exhibit immunomodulatory, antioxidant, antiapoptotic, and
vasoactive properties.6 HO-1 is induced in the kidney in response
to ischemia–reperfusion injury (IRI),7 and the administration of
pharmacological inducers of HO-1 has been attempted with
some success in renal IRI in young animals (reviewed by Nath8).
Expression of HO-1 in macrophages (Mf) opposes
inflammatory activation and autoimmunity,9,10 and is
associated with improved outcome in both hepatic and renal
IRI.11,12 Recent studies have demonstrated that aged animals
undergoing experimental hypoxic/hyperthermic brain injury,
liver heat shock, or lung inflammation exhibit reduced ability
to induce HO-1 compared with young control mice.13–15
This study sought to test the hypothesis that a failure of
HO-1 induction in the aged kidney in response to IRI could
contribute to the susceptibility to AKI seen in the aged
population. Furthermore, the utility of the HO-1 inducer
heme arginate (HA) was tested in an experimental model of
AKI, and its cellular target of action investigated.
RESULTS
Young and 1-year-old mice have equivalent baseline renal
function
Renal function was measured in young (6- to 8-week-old)
and old (52- to 56-week-old) mice. Serum creatinine was not
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significantly different between groups (Figure 1a, 36.6±2.2
vs 40.8±1.9 mmol/l; young vs old mice; P¼not significant
(NS)). Further studies were undertaken using metabolic cage
collections, demonstrating that older animals had normal
24-h creatinine clearance (Figure 1b, 39±5 vs 58±11 ml/min;
young vs old mice; P¼NS) and urinary excretion of both
total protein (Figure 1c, 11.1±2.2 vs 10.8±2.1 mg/24 h;
young vs old mice; P¼NS) and albumin (Figure 1d,
62.3±17.4 vs 56.7±24.2 mg/24 h; young vs old mice;
P¼NS). Assessment of fibrillar collagen deposition with
Picrosirius red (Figure 2a and b) demonstrated equivalent
collagen matrix within the medulla (Figure 2c), but increased
levels of peritubular collagen deposition within the cortex of
older animals (Figure 2d, 2.6±0.5 vs 5.7±0.9% of field
Picrosirius red þ ve; young vs old mice; P¼ 0.015).
Baseline immunohistochemistry was undertaken to examine
the density of the microvasculature by CD31 staining in both
cortex and medulla, which was found to be well maintained in
old animals (Supplementary Figure S1 online). Baseline levels of
intrarenal Mf, T and B lymphocytes, and neutrophils were all
determined by immunohistochemistry (Supplementary Figure
S2A online), with no difference in counts between young and
older mice (Supplementary Figure S2B online).
One-year-old mice exhibit increased renal injury following
renal IRI
To characterize whether 1-year-old mice exhibited an
increased susceptibility to AKI, despite normal basal
excretory function, young and 1-year-old mice underwent
20 min of experimental IRI with contralateral nephrectomy; a
model that causes only mild renal dysfunction in young
female animals, peaking at 24 h post-injury. At 24 h post-
injury, older animals exhibited marked acute renal failure
(Figure 3a, creatinine 38±6 vs 120±35 mmol/l; young vs
1-year–old mice; Po0.01), with increased levels of acute
tubular necrosis (ATN; Figure 3B, images Figure 3d–g,
55±0.4 vs 75±1.2% ATN; young vs 1-year-old mice;
Po0.001). There was significant recruitment of neutrophils
on day 1 in older mice (Figure 3c, 0.4±0.1 vs 22.5±7.3
neutrophils/high power field, P¼ 0.0032) with less neutro-
phil infiltration evident in the young animals. There was no
significant difference in the numbers of Mf, T or B cells
between groups at 24 h (Supplementary Table S1 online).
Older mice fail to upregulate HO-1 protein in the outer
medulla in response to renal IRI
Baseline HO-1 levels were assessed in both cortex and medulla
by immunohistochemistry and image analysis, which demon-
strated low levels of basal tubular HO-1 expression in both the
young and 1-year-old kidney (Figure 4a–c and e). The ability of
the aged animal kidney to induce HO-1 in response to IRI was
assessed by immunohistochemistry to permit spatial localiza-
tion of protein (Figure 4c–f). Within the cortex, both young
and older animals induced HO-1 in response to IRI (Figure
4a), although this induction was blunted in the aged group. In
contrast to young mice, aged animals exhibited significantly less
induction of HO-1 within the medulla in response to IRI
(Figure 4b, P¼ 0.0013). Although young mice exhibited nearly
twofold greater number of viable medullary tubules after IRI
(44.8 vs 24.5%; young vs year old mice), the greater than
fivefold increase in medullary HO-1 expression in the medulla
of young compared with aged mice indicated that the increased
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Figure 1 |Measurement of baseline renal function in old and
young mice. Young and 1-year-old mice exhibit equivalent
renal excretory function, with comparable serum creatinine
(a, n¼ 10–11/group), measured 24-h creatinine clearance
(b, n¼ 5/group), proteinuria (c, n¼ 6/group), and albuminuria
(d, n¼ 6/group; all P¼ not significant).
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Figure 2 |Quantification of fibrillar collagen within old and
young kidneys. Representative images of fibrillar collagen
deposition shown by Picrosirius red staining (a and b,  200
magnification). Image analysis demonstrates that old animals
exhibit increased levels of fibrillary collagen deposition within the
cortex compared with young controls (c; *P¼ 0.018 young vs old
cortical Picrosirius red staining, n¼ 5/group). Further selective
analysis of cortical images revealed that this excess was wholly
due to peritubular rather than intraglomerular collagen
accumulation (d; P¼ 0.015 young vs old peritubular staining).
HPF, high power field.
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induction was not simply an artifact of increased tubular
viability.
Treatment of aged mice with HA results in renal HO-1
induction
To probe whether the failure to induce HO-1 was of
functional significance in old mice, the HO-1-inducing agent
HA was administered to 1-year-old mice 24 h before IRI.
Western blots for HO-1 were performed on whole kidney
homogenate (Figure 5a), and densitometric analysis was
performed showing robust protein induction (Figure 5b;
Po0.0005, phosphate-buffered saline (PBS) vs HA). Im-
munohistochemical staining for HO-1 demonstrated induc-
tion in cortical tubules in HA pretreated animals (Figure 5d
vs PBS control Figure 5c), resulting in markedly increased
total cortical staining, which was maintained in the aftermath
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Figure 3 |Outcome after renal ischemia-reperfusion injury in young and old mice. Old mice demonstrate worse functional
derangement after ischemia–reperfusion injury (IRI; a; *P¼ 0.016, n¼ 5/group), with associated increased levels of acute tubular necrosis
(b; ***Po0.0001). The increased injury in old mice was associated with increased recruitment of neutrophils from baseline (c; *P¼ 0.0032).
Hematoxylin and eosin images of young kidney pre-IRI (d) and post-IRI (e), and old kidney pre-IRI (f) and post-IRI (g) (all images  100).
PMN, polymorphonuclear neutrophil; HPF, high power field.
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Figure 4 |Renal hemeoxygenase-1 expression after IRI in young and old kidneys. Hemeoxygenase-1 (HO-1) protein is induced in the
cortex of old and young mice in response to ischemia–reperfusion injury (IRI; a, P¼ 0.21 young d1 vs old d1, n¼ 4–7/group), while there is a
failure to induce HO-1 in the medulla of old mice (b, **P¼ 0.0013 young d1 vs old d1, n¼ 4–7/group). Immunohistochemistry of HO-1
protein distribution in young animal kidney pre-IRI (c) and post-IRI (d), and old kidney pre-IRI (e) and post-IRI (f) (main images  50, insets
 125).
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of IRI (Figure 5e, Po0.001 vs PBS treatment d0, Po0.01 vs
PBS treatment d1). HA pretreatment increased HO-1
staining within the medulla with a further increase evident
after IRI relative to PBS control (Figure 5f, Po0.05 d1 vs PBS
treatment).
The effect of HA administration on circulating leukocyte
number was assessed by flow cytometry. HA administration
did not result in a significant change in total leukocyte
number compared with sham injection (5.9±1.2 vs
4.1±0.3 106 cells/ml whole blood, HA vs PBS; P¼ 0.21,
Supplementary Figure S3A online). Further analysis demon-
strated that HA treatment was associated with an increase in
circulating neutrophil counts and a decrease in Gr1þ
monocytes (both P¼ 0.03 vs pretreatment counts, summar-
ized in Supplementary Figure S3B–F online).
Heme arginate pretreatment of aged mice ameliorates renal
failure and tissue injury after IRI
To assess the potential for HO-1 induction as a therapeutic
intervention in aged animals, renal IRI was performed in old
animals 24 h after either intravenous injection of PBS
(oldþ PBS) or HA (oldþHA), with further young animals
as controls (youngþ PBS). HA therapy was associated
with marked functional protection (Figure 6a: creatinine
128.5±31.5 vs 49.6±6.3 vs 68.0±10.0 mmol/l; oldþ PBS vs
oldþHA vs youngþ PBS; Po0.05). This was associated with
a marked reduction in the severity of ATN in HA pretreated
animals (Figure 6b–f: 58.4±12.9 vs 21.0±6.5 % ATN;
oldþ PBS vs oldþHA; Po0.05).
Heme arginate treatment induces HO-1 expression in
interstitial cells of the kidney
In PBS-treated older animals, there were virtually no HO-1þ
interstitial cells evident at baseline (Figure 7a), but HO-1þ
interstitial cells were evident within injured areas after IRI
(Figure 7b). Furthermore, after HA treatment, numerous
interstitial cells were observed to express HO-1 (Figure 7c),
and these HO-1þ interstitial cells were present in maintained
numbers after IRI (Figure 7d and e). Indeed, these HO-1þ
interstitial cells formed the principal site of HO-1 expres-
sion within the injured medulla (Figure 7b). Given the
morphological and anatomical resemblance of these HO-1þ
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Figure 5 | Effects of heme arginate administration on renal hemeoxygenase-1 expression. Pretreatment with heme arginate (HA) at a
dose of 30mg/kg results in the induction of total kidney hemeoxygenase-1 (HO-1) protein by western blotting (a, positive control of liver
homogenate: lane 2, vehicle-treated kidney: lanes 3–6, HA-treated kidney: lanes 7–10), and subsequent densitometric analysis
(b, ***Po0.001). HO-1 expression in the cortex of old mice was minimal following phosphate-buffered saline (PBS) injection (c).
HO-1 expression was markedly induced in the uninjured cortex following injection of HA (d). Image analysis demonstrated increased cortical
HO-1 expression (e, **Po0.001 HA pre-ischemia–reperfusion injury (IRI) vs PBS pre-IRI; *Po0.01 HA post-IRI vs PBS post-IRI; n¼ 5/group) and
increased medullary HO-1 (f, *Po0.05 HA post-IRI vs PBS post-IRI; n¼ 5/group) expression following HA treatment.
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Figure 6 | Effect of heme arginate administration on renal injury and function after IRI in old animals. Heme arginate (HA)
pretreatment of aged mice results in significant functional protection from ischemia–reperfusion injury (IRI) compared with vehicle-treated
controls (a; *Po0.05; oldþphosphate-buffered saline (PBS) vs oldþHA, n¼ 5–7/group). There was an associated reduction in the extent
of acute tubular necrosis between groups (b; *Po0.05; oldþ PBS vs oldþHA). Representative images demonstrate renal histology in
PBS-treated mice pre-injury (c), PBS post-injury (d), HA-treated mice pre-injury (e), and HA post-injury (f) (all images  200 magnification).
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Figure 7 |Characterization of hemeoxygenase-1 expressing cells in the renal interstitium. Hemeoxygenase (HO)-1þ interstitial cells
are not present at baseline in old mice (a) but are evident following ischemia–reperfusion injury (IRI; b). Heme arginate (HA) administration
results in an increased number of cells within the interstitial compartment of the outer medulla, which are strongly positive for HO-1 both
pre- and post-IRI (c, pre-IRI d, post-IRI, e, mean HO-1þ cell per high powered medullary field (HPF); *Po0.05 HA d0 vs phosphate-buffered
saline (PBS) d0, n¼ 5/group). Immunofluorescence of frozen sections for CD68 Alexa-488 (f), HO-1 Alexa-568 (g), and 4,6-diamidino-2-
phenylindole (DAPI) (h) demonstrates multiple areas of colocalization (i), dual-positive cells marked with arrows) indicating that
macrophages express HO-1 in the kidney in response to IRI or HA treatment.
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interstitial cells to renal Mf, dual immunostaining with the
resident Mf/dendritic cell marker CD68 was performed,
demonstrating multiple areas of colocalization (Figure 7f–i),
thereby indicating that one target of HA action is the resident
mononuclear phagocyte population of the kidney.
Heme arginate treatment induces HO-1 in primary bone
marrow-derived macrophages in vitro
To further demonstrate the ability of HA to upregulate Mf
HO-1 expression, studies were undertaken in primary
cultures of murine bone marrow-derived Mf (BMDM).
Twenty-four hours treatment of Mf with HA (10 mmol/l)
significantly increased HO-1 protein expression by western
blot (Supplementary Figure S4A online) and immunofluor-
escence (Supplementary Figure S4B–E online). Increased
HO-1 protein expression persisted for 24 h, following
removal of HA containing media from the Mf.
The effect of HA treatment on resting and classically
activated Mf phenotype was tested by stimulation with
lipopolysaccharide and interferon-g after preincubation with
a range of HA doses. HA treatment per se had no activating
effect on Mf (Supplementary Figure S4F online). Impor-
tantly, the cells also had preserved and unaltered ability to
upregulate tumor necrosis factor-a in response to classical
activating stimuli (Supplementary Figure S4F online, P¼NS
by analysis of variance, n¼ 3/group).
Macrophage depletion results in loss of HA-induced renal
protection
Our data indicated that interstitial cells, including Mf,
represented an important site of HO-1 induction within the
medulla of HA pretreated mice, and are either induced or
recruited in PBS-treated animals in response to ischemic
medullary injury. We therefore sought to probe the relative
contribution of HO-1þ interstitial Mf to the protected
phenotype induced by treatment with HA. We used 1-year-
old CD11b-DTR mice, in which Mf can be selectively
depleted from the kidney by administration of diphtheria
toxin (DT).16,17 Aged CD11b-DTR mice were pretreated with
either PBS, DTþ PBS, HAþ PBS, or HAþDT before
undergoing renal IRI. Animals treated with DT exhibited a
75% reduction in resident F4/80þ Mf counts (11.5±2.3 vs
2.9±0.7 F4/80þ cells/ 400 field; PBS vs DT treatment;
P¼ 0.0024).
In the cortex, where the predominant site of HO-1
induction was tubular, there was no difference in the level of
HO-1 induction in day 0 nephrectomy specimens from
DT-treated animals (Figure 8c). In contrast, DT pretreatment
resulted in a five- to sixfold reduction in day 0 HO-1 staining
in the medulla, where HO-1þ interstitial cells represent the
major site of HO-1 expression (Figure 8d, P¼ 0.08). HO-1þ
interstitial cells were then counted in the aftermath of IRI
(Figure 8a and b), and were reduced by 60% in mice treated
with HAþDT compared with mice treated with HA
alone (Figure 8e: 4.2±1.6 vs 10.4±2.0 HO-1þ interstitial
cells/high power field; HAþDT vs HAþ PBS; Po0.05),
indicating that CD11bþ Mf represent the majority of
HO-1þ interstitial cells.
When functional outcome after IRI was assessed,
HAþ PBS-treated mice again demonstrated a markedly
protected functional phenotype, which was abolished in
HAþDT-treated mice (Figure 8f: creatinine 43.4±3.3 vs
75.3±11.6 vs 74.2±11 vs 103.2±22 mmol/l; HAþ PBS
vs HAþDT vs PBS vs DTþ PBS; Po0.05 HAþ PBS vs
HAþDT). Consistent with this, HAþ PBS-treated animals
demonstrated a significant reduction in the extent of acute
tubular necrosis, which was not present in the context of
concurrent Mf depletion (Figure 8g: ATN score 20±8.1 vs
50.6±7.3% vs 54±10 vs 58.9±10.1% outer stripe of the
outer medulla necrosis; HAþ PBS vs HAþDT vs PBS
vs DTþ PBS; Po0.05 HAþ PBS vs all groups).
DISCUSSION
These data demonstrate that while expressing comparable
levels of baseline protein, the older animal kidney has an
impaired ability to upregulate HO-1 in response to IRI, and
demonstrates a worsened injury phenotype compared with
young animals. HA administration to 1-year-old animals
robustly induces HO-1 protein expression in both cortical
tubules and interstitial medullary Mf, and provides aged
mice with both structural and functional protection from
IRI. This protected phenotype is absent in animals treated
with HA coupled with conditional Mf ablation, strongly
implicating the interstitial Mf as the key therapeutic target
for HA.
Earlier work has described histological changes in kidneys
of aged rats, with interstitial fibrosis, progressive tubular
injury, glomerulosclerosis, and leukocyte recruitment.18
While there was evidence of increased deposition of fibrillar
collagen around the cortical tubules of aged animals, this was
not associated with any capillary rarefaction or leukocyte
infiltration. Such differences may reflect species and strain
differences in the aging process, and also the earlier time
point of 52–56 weeks chosen for the mouse studies presented
here. Intriguingly, and in contrast to population studies
in humans, studies of rats subjected to IRI after 5/6th
nephrectomy, with resultant proteinuria and fibrosis, saw no
increase in AKI severity,19 thereby suggesting that reduced
nephron number, fibrosis, and disruption of glomerular
integrity are not absolute predictors of a worse outcome
after IRI.
It is debatable to what ‘human age’ the mice examined in
this study are equivalent. Laboratory mice in specific
pathogen-free housing live considerably longer than their
wild equivalents, with the 1-year-old time point studied here
representing the average life expectancy for a wild mouse.
While laboratory animals can live to twice this age, the
majority of FVB strain mice have developed tumors by
24 months of age, confounding their experimental use.20
Indeed preliminary studies were attempted in animals 18–20
months old, but were confounded by the high rates of
malignancies discovered at laparotomy, and husbandry
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concerns regarding the relative frailty of the subjects before
surgical intervention. Accordingly, the results as presented
likely reflect the altered physiological response of subjects in
the later third and fourth quartiles of pathogen-free
population age.
It is well established from registry data that increasing
age is a significant risk factor for AKI.2 Similarly, there are
precedents in rat models of renal IRI demonstrating that aged
animals have a more marked reduction in the glomerular
filtration rate associated with a marked increase in renal
vasoconstriction.21 Given the absence of either nephrotoxic
drugs or indeed diverse intercurrent illnesses in the data
presented here, such findings support the hypothesis that
there are intrinsic alterations within the aged animal kidney
that influence its response to a hypoperfusion insult. Given
that pre-existing chronic renal failure is a major additional
risk factor for AKI and subsequent end-stage renal failure in
patients,3 it was important to establish whether ‘renal
senescence’ had led to a detectable sign of incipient renal
impairment within the aged animals. The equivalence of
measured creatinine clearance and albumin excretion rate
demonstrated by the groups provided acceptable surrogates
for the study of de novo AKI.
The finding of a reduced ability to upregulate HO-1
within the aged murine kidney echoes findings in other
rodent models of inflammatory disease in bowel,22 liver,13
and brain.14 These conserved effects across both species and
organ systems would support this being a fundamental
component of the aging process. The potential for HO-1
deficiency to impact on disease states is demonstrated
by clinical data from renal transplantation, pulmonary
emphysema, and atherosclerosis, where patients with tran-
scription reducing polymorphisms in the human HO-1 gene
have worsened disease phenotypes (reviewed by Exner
et al.23)
HO-1 is induced by a diverse range of noxious stimuli
(reviewed by Wagener et al.6), but the mechanism by which
HO-1 fails to respond to inducing stimuli in the aged
remains incompletely characterized. The HO-1 inducing
transcription factor nrf2 represents a plausible target, being a
key mediator of the IRI-mediated stress response such that
genetic ablation of nrf2 results in worsened severity of renal
IRI.24,25 Nrf2 is also a pathway of pharmacological HO-1
induction,26 and its basal levels have been shown to be
suppressed in astrocytes of aged mice.27 As such, this remains
an area of ongoing investigation. Downstream of HO-1, both
HA and hemin (a related HO-1 inducer) inhibit nuclear
factor-kB;28,29 a key pathway mediating classical Mf
activation with nuclear factor-kB inhibition previously
demonstrated to modulate experimental renal disease.30
Given the vital role played by the Mf as an effector arm of
the innate immune system, it is of note that the in vitro
experiments demonstrated that HO-1 induction was
achieved without blunting of the ability to adopt a classically
activated phenotype. This is important if the therapeutic
translation of these therapies into an elderly patient
population is not to be curtailed by the threat of
immunosuppression and infection.
It is known that IRI induces HO-1 mRNA, protein, and
activity in young experimental animals.7,31 Additionally, data
from pre- and post-implantation biopsies of human renal
allografts demonstrates that HO-1 induction is maximal in
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Figure 8 | Effects of macrophage depletion on heme arginate induced protection from IRI. Macrophage depletion of CD11b-DTR
transgenic mice results in loss of the interstitial hemeoxygenase (HO)-1þ cells induced by heme arginate (HA) treatment (a: HA treatment,
b: HA treatmentþMf depletion, arrows indicate HO-1þ cells). Image analysis demonstrates preserved cortical HO-1 induction (c), but a
trend towards reduced medullary staining for HO-1 (d; P¼ 0.08 HA vs HAþdiphtheria toxin (DT), n¼ 5/group). Quantification of interstitial
HO-1þ cells demonstrates a significant reduction in medullary interstitial HO-1þ cells in HAþDT cotreated animals at d1 post-injury (e;
*Po0.05 HA vs HAþDT). The functional (f; *Po0.05 HA vs HAþDT) and structural (g; *Po0.05 HA vs HAþDT) protection of HA
pretreatment is abolished in mice depleted of renal Mf. NS, not significant.
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organs subject to delayed graft function.32 Although such
tissue homogenate-based methods do not allow interrogation
of the specific cellular sites of HO-1 induction, studies using
hemin as an inducing agent have demonstrated induction of
HO-1 in both tubular and peritubular cells by immuno-
histochemistry.33,34 Our findings demonstrate that HO-1
induction occurs in both cortical tubules and within the
interstitial cells of both cortex and medulla in response to IRI
and HA administration. HO-1 induction in organ resident
Mf has been demonstrated to be of benefit in hepatic IRI,12
and is thought to represent a component of the bene-
ficial effects of statins on various disease models including
renal IRI.11
Despite widespread tubular induction of HO-1 protein
being present in response to HA therapy, the protected
phenotype associated with this therapy was abolished in
animals subject to conditional Mf ablation. There is a
published literature demonstrating that Mf depletion per se
is not deleterious in renal IRI, and indeed systemic
administration of clodronate liposomes leads to widespread
Mf depletion in the liver, spleen, and kidneys and improved
outcome in renal IRI.35,36 Our findings demonstrate that
HO-1þ Mf are key contributors to mediating HA-induced
protection following IRI. This would be consistent with
previous work in the liver demonstrating that depletion of
HO-1þ Kupffer cells sensitized the liver parenchyma to
subsequent IRI injury.12 Although DT does not ablate major
Mf pools within the liver and spleen, it remains possible that
that extra-renal Mf populations contribute to the protective
effects of HA.
The phenotype of Mf-ablated animals suggests that the
induction of HO-1 within non-myeloid lineages both within
the kidney and at extra-renal sites is dispensible for the
generation of a protective phenotype. Similarly, the systemic
release of HO-1 generated carbon monoxide leading to
altered circulatory responses would not appear critical to
organ protection, unless such a factor was being generated
exclusively by a myeloid cell population that was effectively
depleted by the administration of DT. Interestingly, although
circulating neutrophil numbers were increased by HA
treatment, infiltration into the tissue was reduced, augering
against this being of pathogenic significance. HO-1þ Mf
appear to facilitate the survival of medullary tubules, a
finding which echoes results from studies of the developing
kidney in which the resident embryonic Mf population are
trophic for tubular growth and survival.37 The identity of the
HO-1þF4/80 cells also visible by immunofluorescence
remains unresolved, but may reflect the heterogeneity of
the marker profile of Mf/dendritic cells within the kidney,38
where at least 28% of resident renal CD11bþCX3CR1þ
mononuclear phagocytes are F4/80.39
The data set as presented demonstrate an association
between the presence of HA-induced HO-1 expressing renal
Mf and improved outcome after IRI. These studies do not
allow conclusions to be drawn as to whether HO-1 itself
directly mediates this reduction in injury severity or is acting
as a marker of a beneficial Mf population. The ability to
selectively inhibit Mf HO-1 in cell lineages would permit
further dissection of the role of Mf HO-1 in disease
evolution, and the recent generation of the HO-1MKO mice
lacking HO-1 in myeloid cells9 could facilitate experiments
leading to definitive conclusions regarding the role of Mf
HO-1 induction in mediating the phenotype presented here.
HO-1MKO mice exhibit a pattern of augmented bacterial
killing and worsened autoimmune phenotype consistent with
HO-1 acting as a ‘molecular brake’ on Mf cytotoxicity.
Published work, consistent with the findings from the
HO-1MKO mouse, suggests that overexpression of HO-1 in a
model of shock liver results in an inhibition of inflammatory
cytokine production with reduced tumor necrosis factor-a
and augmented interleukin-10 release.40 Our own recent
work has demonstrated a similar pattern of tumor necrosis
factor-a and interleukin-10 production in lipopolysacchar-
ide/interferon-g-stimulated primary murine macrophages
following adenovirally mediated HO-1 overexpression.41 In
these experiments administration of HO-1 overexpressing
Mf after IRI improved subsequent renal function.
Taken together, these findings demonstrate that HO-1þ
interstitial Mf are beneficial in renal IRI, with a failure in
their generation associated with the increased susceptibility
to IRI exhibited by aged animals. Furthermore, HA can
potently induce these cells in aged mice and restore a
protected phenotype. As HA is licenced for use in humans (as
a treatment for porphyria), it has translatable potential as a
novel therapeutic strategy for the prophylaxis of AKI in
susceptible populations, such as the elderly undergoing major
surgery or on admission to critical care environments.
MATERIALS AND METHODS
Materials and reagents
Tissue culture reagents were purchased from Life Technologies
(Paisley, UK). Tissue culture plastics were obtained from
Costar (Loughborough, Leicestershire, UK) and Falcon (Runcorn,
Cheshire, UK). All other reagents were from Sigma-Aldrich
(Poole, UK) unless otherwise stated.
Culture of primary BMDM
BMDM were prepared from FVB/nj mice as previously described.42
Bone marrow was isolated from femurs using aseptic technique and
cultured for 7 days in teflon-coated pots in Dulbecco’s modified
Eagle’s medium/F12 with 10% heat-inactivated fetal calf serum,
penicillin (100 U/ml), streptomycin (100 mg/ml) and 20% L929 cell-
conditioned medium containing macrophage colony-stimulating
factor. Mf differentiation was confirmed by staining with F4/80-
PerCP and CD11b-FITC antibodies (both BD Biosciences, Oxford,
UK) before analysis by flow cytometry (Supplementary Figure S5
online). Cytospins were prepared, fixed with ice-cold methanol and
stained for HO-1 as described below.
In vitro cytokine and nitrite measurements
BMDM (5 105) were plated in 12-well plates and stimulated
with lipopolysaccharide and interferon-g (100 ng/ml and 10 ng/ml,
respectively) for 24 h after 24 h of pretreatment with HA (doses from
10 to 100 mmol/l). Mouse tumor necrosis factor-a in the supernatant
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was quantitatively measured by sandwich ELISA (R&D system,
Abingdon, UK) in accordance with the protocol provided. Absorbance
was read at 450 nm and concentration determined by reference to a
standard curve.
Murine model of IRI
Female mice aged either 6–8 weeks old (young) or 1-year-old (old)
on the FVB/nj strain background were used from in-house colonies.
Both age groups were confirmed to be menstruating by measure-
ment of gonadotrophin levels. Procedures were performed
under Home Office licences 60/3340 and 60/10547. Anesthesia was
induced using Ketamine and Metatomidine via the intraperitoneal
route, with Buprenorphine analgesia subcutaneously. By a midline
laparotomy a right nephrectomy was performed and the left renal
pedicle identified and clipped using an atraumatic clamp for 20 min.
During the ischemic period, body temperature was maintained
using a heating blanket with homeostatic control (Harvard
Apparatus, Boston MA) via a rectal temperature probe. The clamp
was then removed, the peritoneum closed with 5/0 suture and the
skin closed with clips, and anesthesia reversed using atipamazole.
One ml sterile saline was administered subcutaneously before and
after surgery. The animals were maintained in an incubator
overnight, with further subcutaneous administration of saline given
the next morning. Blood and tissue samples were obtained at the
time of surgery (d0) and 24 h post-surgery (d1) under terminal
anesthesia.
Induction of HO-1 protein
Heme arginate (Orphan Europe, Paris, France) was administered
intravenously to selected animals at a dose of 30 mg/kg 24 h before
induction of IRI (equating in vivo to 38 mmol/l). Paired control
animals received equal volumes of PBS. To induce HO-1 in BMDM
cultures, cells were cultured for 24 h with 10 mM HA.
Conditional macrophage ablation
For experiments examining ablation of Mf, CD11b-DTR animals
(FVB/nj background) expressing the receptor for human DT under
the control of the CD11b promoter were used as previously
described.16,17,43 On the basis of the previous work, a dose of 10 ng/g
body weight of DT was administered to CD11b-DTR or wild-type
controls 24 h before IRI to induce renal Mf ablation at the time
of surgery.
Collection and staining of whole blood for leukocyte
populations
Animals were restrained and 25ml of whole blood was venesected via
a tail vein nick. To ensure consistent sample volumes, 25ml blood was
collected from the tail nick using a pipette that already held 25ml
4.5% citrate solution, resulting in immediate anticoagulation of the
collected blood. Samples were stained with CD11b-FITC and Gr1-PE
fluorescence-activated cell sorter antibodies, before red cell lysis was
performed using BD FACSLyse solution (BD Biosciences) and sample
aquisition on a BD FACSCaliber flow cytometer. Analysis was
performed using FlowJo software (Treestar, Ashland, OR).
Assessment of renal function
Creatinine concentration in urine and plasma samples was analyzed
by the Jaffe method (Alpha Laboratories, Eastleigh, UK) on a Cobas
Fara Centrifugal Analyser (Roche Diagnostics, Welwyn Garden City,
UK) according to the manufacturer’s instructions. Mouse urine
albumin levels were measured by a commercial immunoturbidi-
metric kit (Olympus UK, Watford, UK) adapted for use on the
Cobas Fara. The assay was standardized against purified mouse
albumin standards.
Western blotting of HO-1 protein
Renal tissue samples were homogenized in lysis buffer (20 mmol/l
Tris-HCl, 1 mmol/l EDTA (pH 8.0), 150 mmol/l NaCl and 1% (v/v)
Triton-X) supplemented with commercially available antiprotease
tablets (Amersham Biosciences, Little Chalfont, UK) and spun at
18,000 g for 15 min, after which the liquid phase was mixed with
equal volumes of 2 laemmli buffer (4% SDS, 20% glycerol, 10%
2-mercaptoethanol, 0.004% bromphenol blue, and 0.125 mol/l
Tris-HCl) before heating to 95 1C for 5 min. Protein concentrations
from in vivo homogenates or in vitro cell lysates were estimated by
the Bio-Rad protein assay reagent (Bio-Rad Laboratories, Hercules,
CA). Western Blotting was performed as previously described.44
Following electrophoresis onto Hybond-P membranes (Amersham,
Arlington Heights, IL), the membranes were blocked with 5% dried
milk, then incubated overnight at 4 1C with polyclonal rabbit anti-
rat antibody (1:5000 dilution; Stressgen Biotechnologies, Vancouver,
Canada). After washing in Tris-buffered saline with 0.1% Tween, the
blots were incubated with secondary antibody (horseradish
peroxidase-conjugated goat anti-rabbit, Sigma) for 1 h. Blots were
visualized using the ECL Plus system (Amersham Biosciences).
Protein loading was confirmed by reprobing the membranes with
anti-b-actin antibody (Sigma, Poole, UK). Densitometric analysis of
the images was performed using ImageJ software (ImageJ 1.36b;
National Institutes of Health, Bethesda, MD).
Immunohistochemistry
Whole kidneys were cut longitudinally and either snap-frozen in
liquid nitrogen or fixed in methyl carnoy’s solution (60% methanol,
30% chloroform, and 10% acetic acid) or 4% paraformaldehyde
before embedding in paraffin. Four mm tissue sections were cut
and stained with hematoxylin and eosin for assessment of medullary
acute tubular necrosis, and Picrosirius red for assessment of fibrillar
collagen.
For endothelial staining, paraformaldehyde-fixed sections re-
ceived proteinase K antigen retrieval before staining with Rabbit
anti-CD31 Ab (1:100 dilution; BD Pharmingen). Embedded tissue
was deparaffinized in xylene, rehydrated and blocked using 3% H202
before incubation with rat anti-F4/80 monoclonal antibody (1/250
dilution; Caltag Laboratories, Northampton, UK) for Renal Mf
quantification. Infiltrating neutrophils were identified by nuclear
morphology combined with immunostaining for the Gr1 (Ly6c/g)
antigen using Rat anti-Gr1 monoclonal antibody (1/250 dilution;
Cambridge BioScience, Cambridge, UK). Tissue localization of HO-
1 was determined following staining with rabbit anti-mouse HO-1
(1/250 dilution; Cambridge BioScience). Primary antibodies were
incubated at 4 1C overnight with subsequent incubation with
species-specific biotinylated secondary antibody (rabbit anti-rat
immunoglobulin-G or goat anti-rabbit immunoglobulin-G, both
1/300 dilution; Vector Laboratories, Peterborough, UK) at room
temperature for 30 min. After washing, sections were incubated with
Vectastain ABC Elite reagent (Vector Laboratories, Peterborough,
UK) for 30 min at room temperature, before washing and staining
with diaminobenzidine (Dako UK, Cambridgeshire, UK). Counter-
staining was performed with hematoxylin before dehydration
and mounting. In all cases, appropriate isotype antibodies were
used as negative controls. Mf and neutrophils were identified by
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morphology and staining pattern, and expressed as mean cells per
 400 microscope field, with five fields being assessed per section.
Tubules within the outer stripe of the outer medulla were
photographed and tubules were counted as viable or necrotic based
on nuclear morphology and the integrity of the epithelial cell layer
using ImageJ software (Cell counter plugin; ImageJ 1.36 b; National
Institutes of Health, Bethesda, MD). CD31 and Picrosirius red
staining was quantified on images acquired  200 as above, with
subsequent analysis of positive staining performed using Colour
Range tool on Photoshop CS3 Extended (Version 10.0.1; Adobe
Systems Europe, Uxbridge, UK). Results were expressed as a
proportion of image pixels positive for CD31 or Picrosirius red.
Immunofluorescence
Frozen tissue was embedded in 22-oxacalcitriol mounting media
and 5 mm sections cut, air-dried and fixed in ice-cold acetone. For
in vitro preparations, cytospins were prepared as described above.
After protein blockade (Spring Bioscience, Pleasanton, CA) primary
antibodies (polyclonal rabbit anti-HO-1, rat anti-mouse CD68)
were added at 1:250 dilution and incubated for 1 h at room
temperature. Following washing in PBS, secondary antibodies
(Alexa-568-conjugated goat anti-rabbit immunoglobulin and
Alexa-488 donkey anti-rat immunoglobulin-, both from Invitrogen,
Paisley, UK) were added at 1:500 dilution for 1 h. Slides were
coverslipped with Vectashield-containing DAPI (Vector Labora-
tories) before microscopy and image aquisition. Image analysis was
performed as previously described using Photoshop CS3.
Statistical analysis
All data are expressed as mean±s.e.m. The Student’s unpaired t-test
was used to compare two groups. Where multiple conditions
were compared, the one-way analysis of variance for repeated
measurements was used. P-values o0.05 were taken as representing
statistical significance. All statistical analysis was performed using
GraphPad Prism version 4.0c for Macintosh (GraphPad Software,
San Diego, CA, www.graphpad.com).
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SUPPLEMENTARY MATERIAL
Figure S1. Identification of the renal microvaculature using
immunohistochemistry for the CD31 antigen.
Figure S2. Typical immunohistochemical appearances of cortex and
medulla of young and old kidneys (A).
Figure S3. FACS analysis of whole blood before and after HA
administration (or PBS control) demonstrates no alteration in total
leukocyte counts at 1 day after injection (A).
Figure S4. Western blotting of protein homogenate from bone
marrow-derived macrophages, demonstrates progressive induction
of HO-1 up to 24h of exposure to heme arginate, which was
maintained for up to 48 h after removal of HA containing media (A).
Figure S5. Bone marrow-derived macrophages co-express high levels
of the classical macrophage markers CD11b and F4/80 by flow
cytometry after 7 days culture in vitro.
Table S1. Summary of tubular necrosis scores, hemeoxygenase
protein levels and leukocyte counts in young and old mice after
ischaemia-reperfusion injury.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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